TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34039573

Group type: EXPERIMENTAL
Intervention: Casting in bayonet position
Number of subjects: 60
Study: 32311960

Group type: EXPERIMENTAL
Intervention: Liang‐Xue‐Di‐Huang Decoction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36176465

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting cancer-specific survival (CSS)
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Cox regression model
Number of subjects: 970
Study: 33492208

Group type: EXPERIMENTAL
Intervention: 30 mg of lansoprazole twice daily for 16 weeks
Number of subjects: 346

Group type: COMPARATOR
Intervention: Matched placebo for 16 weeks
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: 30 mg of lansoprazole for 12 months
Number of subjects: 346

Group type: COMPARATOR
Intervention: Matched placebo for 12 months
Number of subjects: 346

Group type: COMPARATOR
Intervention: Lansoprazole and placebo
Number of subjects: 346
Study: 33895386

Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach (DAA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Direct lateral approach (DLA)
Number of subjects: 70
Study: 33264302

Group type: EXPERIMENTAL
Intervention: B7A strain at 108 cfu with overnight fast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: B7A strain at 109 cfu with 90-minute fast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: B7A strain at 109 cfu with overnight fast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: B7A strain at 1010 cfu with 90-minute fast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rechallenge with B7A strain at 109 cfu with overnight fast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Concurrent challenge naïve subjects with B7A strain at 109 cfu
Number of subjects: 28
Study: 36126995

Group type: EXPERIMENTAL
Intervention: Usual CF care plus longitudinal palliative care intervention delivered by a palliative care specialist
Number of subjects: 264

Group type: COMPARATOR
Intervention: Usual CF care alone
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Usual CF care plus longitudinal palliative care intervention
Number of subjects: 264
Study: 32207859

Group type: EXPERIMENTAL
Intervention: Autonomy support through dialogic learning (experimental group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 102
Study: 33752794

Group type: EXPERIMENTAL
Intervention: FENIX (magnetic sphincter augmentation device)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation
Number of subjects: 99

Group type: COMPARATOR
Intervention: FENIX
Number of subjects: 99
Study: 35297692

Group type: EXPERIMENTAL
Intervention: EMME + pauses (EMME + P)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: EMME without pauses (EMME-NoP)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Pauses only (NoEMME + P)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: No EMME and no pause (NoEMME-NoP)
Number of subjects: 195
Study: 34006539

Group type: EXPERIMENTAL
Intervention: Workers on workdays
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Workers on days off
Number of subjects: 190

Group type: COMPARATOR
Intervention: Retirees on weekdays and weekend days
Number of subjects: 190
Study: 33048635

Group type: EXPERIMENTAL
Intervention: Interactive video program of African American breast cancer survivor stories
Number of subjects: 108
Study: 36174033

Group type: EXPERIMENTAL
Intervention: 30% of one-repetition maximum (1RM) (low-load)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 80% of one-repetition maximum (1RM) (high-load)
Number of subjects: 48
Study: 34340986

Group type: EXPERIMENTAL
Intervention: EZ‐IO drill
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: NIO‐I needle
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Jamshidi needle
Number of subjects: 92
Study: 32278303

Group type: EXPERIMENTAL
Intervention: Novel quantitative personal hygiene assessment tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional qualitative cleanliness metrics
Number of subjects: 0
Study: 34391722

Group type: EXPERIMENTAL
Intervention: Minimal-Invasive Envelope Flap (MIEF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional Envelope Flap (CEF)
Number of subjects: 34
Study: 34620620

Group type: EXPERIMENTAL
Intervention: High protein-high fat with alcohol (0.7g/kg body weight, beer)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High protein-high fat without alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low protein-low fat without alcohol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alcohol consumption with mixed meal
Number of subjects: 12
Study: 36453045

Group type: EXPERIMENTAL
Intervention: Decompression with fusion
Number of subjects: 222

Group type: COMPARATOR
Intervention: Decompression alone
Number of subjects: 222
Study: 34765482

Group type: EXPERIMENTAL
Intervention: MTEI-(I) at 1 mL/kg/d (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MTEI-(I) at 2 mL/kg/d (Group B)
Number of subjects: 40
Study: 32896089

Group type: EXPERIMENTAL
Intervention: Systematic education, patient diary to mark daily medicine intake, and periodic telephone reminders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 0
Study: 35436911

Group type: EXPERIMENTAL
Intervention: Hearing aids intervention
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 385
Study: 32506663

Group type: EXPERIMENTAL
Intervention: MAPC treatment
Number of subjects: 10
Study: 32796502

Group type: EXPERIMENTAL
Intervention: MARA + SMS
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MARA
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 125
Study: 33594827

Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS) endpoint with conservative definition for treatment failure (TF) events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS) endpoint
Number of subjects: 0
Study: 32133163

Group type: EXPERIMENTAL
Intervention: School-based malaria case management using Learner Treatment Kits (LTK) providing malaria rapid diagnostic tests and artemisinin-based combination therapy.
Number of subjects: 9571

Group type: COMPARATOR
Intervention: Control group (29 schools without the intervention).
Number of subjects: 9571
Study: 33073629

Group type: EXPERIMENTAL
Intervention: Global health education framework
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Integration of global health education
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Global health competencies
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Challenges in global health education
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clarification of global health in rehabilitation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Advancement of literature on global health in rehabilitation
Number of subjects: 12
Study: 32221992

Group type: EXPERIMENTAL
Intervention: Endurance Exercise (EE) - cycling at 60% of peak power output for 50 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resistance Exercise (RE) - five exercise machines at 70% of the one-repetition maximum for 50 minutes
Number of subjects: 24
Study: 34510024

Group type: EXPERIMENTAL
Intervention: 4-month exercise intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study: 32251253

Group type: EXPERIMENTAL
Intervention: Cognitive task (Stroop's color-word conflict test)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Watching a documentary (control)
Number of subjects: 30
Study: 35595003

Group type: EXPERIMENTAL
Intervention: Pretomanid (doses: 50, 100, 200, 400, 600, 800, 1000 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pretomanid (PK analysis, n = 46)
Number of subjects: 60
Study: 32512575

Group type: EXPERIMENTAL
Intervention: NEO stents with anti-stent migration system
Number of subjects: 12
Study: 32702837

Group type: EXPERIMENTAL
Intervention: Sihogayonggolmoryeo-tang (SYM) granules administered twice a day for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list group (no SYM granules)
Number of subjects: 30
Study: 35688623

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose chest CT (ULDCT)
Number of subjects: 2418

Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 2418
Study: 32524512

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin/nab-paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carboplatin/nab-paclitaxel alone
Number of subjects: 0
Study: 36411151

Group type: EXPERIMENTAL
Intervention: Active bTsMS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham bTsMS
Number of subjects: 26
Study: 34173816

Group type: EXPERIMENTAL
Intervention: Ilex paraguariensis leaf infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 14
Study: 32187469

Group type: EXPERIMENTAL
Intervention: Microdiskectomy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Nonsurgical care
Number of subjects: 128
Study: 35963802

Group type: EXPERIMENTAL
Intervention: Olpasiran 75 mg (Japanese group)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Olpasiran 75 mg (Non-Japanese group)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Olpasiran (all doses)
Number of subjects: 27
Study: 32591310

Group type: EXPERIMENTAL
Intervention: Naïve Bayes (NB) model
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Logistic regression
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Artificial neural network
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Random forest
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Support-vector machine
Number of subjects: 849
Study: 34518264

Group type: EXPERIMENTAL
Intervention: guselkumab maintenance dosing every 8 weeks (q8w)
Number of subjects: 0

Group type: COMPARATOR
Intervention: guselkumab investigational maintenance dosing every 16 weeks (q16w)
Number of subjects: 0
Study: 35536044

Group type: EXPERIMENTAL
Intervention: aPDT (antimicrobial photodynamic therapy)
Number of subjects: 46

Group type: COMPARATOR
Intervention: OFD (open flap debridement)
Number of subjects: 46
Study: 33664155

Group type: EXPERIMENTAL
Intervention: Music-based intervention (MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-music control intervention
Number of subjects: 0
Study: 36052904

Group type: EXPERIMENTAL
Intervention: Double-wire fixation and closure (study group)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Single-wire fixation and closure (control group)
Number of subjects: 293
Study: 32462958

Group type: EXPERIMENTAL
Intervention: Pembrolizumab monotherapy (maximum treatment duration of 2 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (platinum doublet)
Number of subjects: 0
Study: 616830555

Group type: EXPERIMENTAL
Intervention: Tomato juice (30 mg of lycopene) consumed daily for 12 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Antioxidant capsule (vitamin C 600 mg, vitamin E 200 mg, glutathione 300 mg) consumed daily for 12 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 34840294

Group type: EXPERIMENTAL
Intervention: Polidocanol foam sclerotherapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Rubber band ligation
Number of subjects: 120
Study: 32242764

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine
Number of subjects: 57

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 57
Study: 34024559

Group type: EXPERIMENTAL
Intervention: Ethiopian body fat percent (BF%) prediction equation
Number of subjects: 704

Group type: COMPARATOR
Intervention: Caucasian body fat percent (BF%) prediction equation
Number of subjects: 704
Study: 33069302

Group type: EXPERIMENTAL
Intervention: Biannual community-wide mass drug administration (MDA) for soil-transmitted helminthiasis
Number of subjects: 36327
Study: 35977854

Group type: EXPERIMENTAL
Intervention: Topical Recombinant Human Nerve Growth Factor (rhNGF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 33596674

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for anterior circulation large vessel occlusion
Number of subjects: 1793

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for posterior circulation large vessel occlusion
Number of subjects: 1793

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for anterior circulation with underlying intracranial atherosclerotic disease
Number of subjects: 1793

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for anterior circulation
Number of subjects: 1793
Study: 32130376

Group type: EXPERIMENTAL
Intervention: Combination of essential balm, vinegar, alcohol, and rose perfume for olfactory training
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 125
Study: 33686804

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 18
Study: 34101740

Group type: EXPERIMENTAL
Intervention: Intervention program aimed at promoting healthy eating habits
Number of subjects: 823
Study: 35226526

Group type: EXPERIMENTAL
Intervention: Prophylactic subcutaneous scopolamine butylbromide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32462935

Group type: EXPERIMENTAL
Intervention: Improvement strategies designed to boost academic success and persistence during the 6-month learning and development (L&D) phase of the program.
Number of subjects: 317
Study: 33513060

Group type: EXPERIMENTAL
Intervention: Self-hypnosis with Elkins Hypnotizability Scale (EHS) induction
Number of subjects: 55

Group type: COMPARATOR
Intervention: Self-hypnosis with Elkins Hypnotizability Scale (EHS) induction and audio recording
Number of subjects: 55
Study: 32610358

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) use, n=44, average of 200 minutes/week, starting 1 week postoperative and continuing through week 12.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) use, n=44.
Number of subjects: 66

Group type: COMPARATOR
Intervention: No NMES, n=22 (control group).
Number of subjects: 66
Study: 33650729

Group type: EXPERIMENTAL
Intervention: Active expiratory muscle strength training for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham handheld device
Number of subjects: 50
Study: 33137572

Group type: EXPERIMENTAL
Intervention: Automated voltage-based algorithm for detecting PGES
Number of subjects: 0
Study: 34108187

Group type: EXPERIMENTAL
Intervention: Narrative intervention (viewing a digital narrative and responding to a writing prompt)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 215
Study: 34956218

Group type: EXPERIMENTAL
Intervention: Oats (80 g daily for 45 days)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Rice (80 g daily for 45 days)
Number of subjects: 210
Study: 35633327

Group type: EXPERIMENTAL
Intervention: Protocol treatment with a course of hepatoprotector for one month
Number of subjects: 57

Group type: COMPARATOR
Intervention: Protocol treatment without hepatoprotector
Number of subjects: 57
Study: 33556319

Group type: EXPERIMENTAL
Intervention: Peginterferon lambda 180 µg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32333570

Group type: COMPARATOR
Intervention: tDCS at 0 μA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tDCS at 500 μA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tDCS at 1,000 μA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tDCS at 1,500 μA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tDCS at 2,000 μA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-stimulation condition
Number of subjects: 0
Study: 36303075

Group type: EXPERIMENTAL
Intervention: Specialist-based follow-up care
Number of subjects: 402

Group type: COMPARATOR
Intervention: Primary care-based follow-up care
Number of subjects: 402
Study: 33504893

Group type: EXPERIMENTAL
Intervention: PD patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 60
Study: 34904225

Group type: EXPERIMENTAL
Intervention: FLAG-Ida
Number of subjects: 115

Group type: COMPARATOR
Intervention: DA/ADE
Number of subjects: 115
Study: 32151443

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting bioresorbable scaffolds (BRS)
Number of subjects: 1614
Study: 35611568

Group type: EXPERIMENTAL
Intervention: Navigated central retinal laser and 2.0 mg aflibercept
Number of subjects: 41

Group type: COMPARATOR
Intervention: Aflibercept monotherapy
Number of subjects: 41
Study: 33096545

Group type: EXPERIMENTAL
Intervention: Heading group (10 headers with soccer balls projected at 25 mph)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Kicking-control group (10 kicks)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Heading group
Number of subjects: 68

Group type: COMPARATOR
Intervention: Kicking-control group
Number of subjects: 68
Study: 36441776

Group type: EXPERIMENTAL
Intervention: Focal irreversible electroporation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Extended irreversible electroporation
Number of subjects: 106
Study: 33647718

Group type: EXPERIMENTAL
Intervention: GNAstV infection (0.5 mL GNAstV‐JSHA intramuscularly)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control (PBS inoculation)
Number of subjects: 40
Study: 32683658

Group type: EXPERIMENTAL
Intervention: Supine transgluteal approach (Group A)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Modified prone approach (Group B)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Prone position approach (Group C)
Number of subjects: 240
Study: 33059389

Group type: EXPERIMENTAL
Intervention: Weight-based teasing (WBT)
Number of subjects: 312
Study: 32916132

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg (2 capsules of 4 mg) administered orally 1 hour before dental extraction
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (2 capsules with same characteristics as dexamethasone) administered orally 1 hour before dental extraction
Number of subjects: 93
Study: 33879223

Group type: EXPERIMENTAL
Intervention: Zhigancao Tang granules
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 33293284

Group type: EXPERIMENTAL
Intervention: Surgical staging (transperitoneal laparoscopy)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Clinical staging
Number of subjects: 255
Study: 35535482

Group type: EXPERIMENTAL
Intervention: Fingernail As concentration
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Fingernail Pb concentration
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Fingernail Hg concentration
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Increasing Se concentration
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Toxicant concentrations (As, Pb, Hg)
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Se status
Number of subjects: 658
Study: 33724251

Group type: COMPARATOR
Intervention: Dasotraline 4 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dasotraline 6 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study: 32980184

Group type: EXPERIMENTAL
Intervention: LC28-0126 (3, 10, 20, or 30 mg doses, infused over 30 min, once daily for 7 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (inactive control vehicle, infused over 30 min, once daily for 7 days)
Number of subjects: 32
Study: 35429465

Group type: EXPERIMENTAL
Intervention: 12-month oral itraconazole
Number of subjects: 164

Group type: COMPARATOR
Intervention: 6-month oral itraconazole
Number of subjects: 164
Study: 33568388

Group type: EXPERIMENTAL
Intervention: LASSO‐LR model for SLE diagnosis
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: LASSO‐LR model for early disease
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: LASSO‐LR model for nephritis
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: LASSO‐LR model for neuropsychiatric lupus
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: LASSO‐LR model for severe lupus requiring immunosuppressives/biologics
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Scoring system based on LASSO‐LR model
Number of subjects: 802
Study: 32160661

Group type: EXPERIMENTAL
Intervention: Conservative oxygen therapy (target Pao2, 55 to 70 mm Hg; Spo2, 88 to 92%)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Liberal oxygen therapy (target Pao2, 90 to 105 mm Hg; Spo2, ≥96%)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Conservative oxygen therapy
Number of subjects: 205
Study: 33548070

Group type: EXPERIMENTAL
Intervention: Industry-funded trials
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Academic/clinical authors
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Payments >$10,000
Number of subjects: 83
Study: 33018534

Group type: EXPERIMENTAL
Intervention: Active RAVANS at 25 Hz
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 35470103

Group type: EXPERIMENTAL
Intervention: Resiliency in Stressful Experiences (RISE) program
Number of subjects: 400

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 400
Study: 33871595

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BOTOX Cosmetic) treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 45
Study: 32209605

Group type: EXPERIMENTAL
Intervention: Endocuff-assisted colonoscopy (ECV+)
Number of subjects: 2058

Group type: COMPARATOR
Intervention: Standard colonoscopy (ECV-)
Number of subjects: 2058
Study: 34699671

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid after dermapen microneedling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical vitamin C after dermapen microneedling
Number of subjects: 20
Study: 34191808

Group type: EXPERIMENTAL
Intervention: Theory-based self-management program (video education and individual counseling by nurses)
Number of subjects: 30
Study: 32185802

Group type: EXPERIMENTAL
Intervention: Sweet orange aromatherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Calm breathing
Number of subjects: 50
Study: 35100060

Group type: EXPERIMENTAL
Intervention: Daytime lighting condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nighttime lighting condition
Number of subjects: 0